Fig. 3From: Synthesis, antibacterial evaluation and in silico studies of novel 2-(benzo[d]thiazol-2-yl)-N-arylacetamides and their derivatives as potential DHFR inhibitorsSynthetic strategy of 2a–c, 4a–r, 6, 8a–c and 11a–f comprising benzo[d]thiazole core 2Back to article page